Pathway-Aware Embedding

Instead of treating each gene as an independent feature, pathway-aware embeddings aggregate multi-omic signals (transcriptomic, proteomic, epigenomic) into pathway activity scores. A single embedding dimension represents the activation state of an entire biological process—such as the PI3K/AKT/mTOR cascade or Wnt signaling—rather than the expression of individual genes. This aggregation is typically performed by mapping genes to pathway databases (Reactome, KEGG, Gene Ontology) and applying statistical enrichment or learned weighted sums.

Because each embedding dimension corresponds to a named, curated biological pathway, model predictions can be directly traced to specific signaling events. A prediction of drug sensitivity can be explained by high MAPK pathway activity rather than an opaque combination of 500 individual gene weights. This property is critical for regulatory compliance and clinical adoption, where black-box genomic models face scrutiny under frameworks like the EU AI Act.

Pathway-aware embeddings serve as a Joint Latent Space where heterogeneous data types converge. A single pathway dimension can integrate:

• Transcriptomic evidence: mRNA abundance of pathway member genes
• Proteomic evidence: protein abundance and phosphorylation states
• Epigenomic evidence: chromatin accessibility at pathway gene promoters
• Metabolomic evidence: flux through pathway metabolites This fusion enables holistic inference even when individual modalities are noisy or partially missing.

The human genome contains approximately 20,000 protein-coding genes, but only a few hundred canonical pathways. By compressing the feature space from the gene level to the pathway level, these embeddings achieve a 100x reduction in dimensionality while preserving mechanistic relevance. This compression is guided by prior biological knowledge rather than purely statistical methods like PCA, making the reduced space inherently meaningful to domain experts.

Individual gene expression measurements are highly susceptible to technical artifacts—batch effects, library preparation bias, and dropout events in single-cell data. Pathway-level aggregation acts as a biological smoothing operator: random noise across individual pathway members cancels out, while coordinated signal across the pathway is amplified. This property makes pathway-aware embeddings particularly valuable for cross-study and cross-platform generalization.

Unlike purely data-driven embeddings, pathway-aware representations incorporate Knowledge-Guided Fusion by design. The model architecture is constrained by known biological interaction networks—edges in pathway databases define which genes contribute to which embedding dimensions. This inductive bias reduces overfitting, improves sample efficiency, and ensures that learned representations respect established biochemical reality rather than discovering spurious correlations.

An integration approach that constrains multi-omic model architecture or training using prior biological databases such as Reactome, KEGG, or Gene Ontology. Unlike purely data-driven fusion, knowledge-guided methods inject mechanistic plausibility by structuring the model's connectivity to mirror known signaling cascades. This ensures that the resulting pathway-aware embeddings are not just statistically correlated but biologically interpretable, allowing researchers to trace predictions back to specific, validated molecular interactions.

A network data structure containing multiple node types (genes, proteins, metabolites) and edge types (physical interaction, co-expression, phosphorylation) used as input for pathway-aware models. These graphs serve as the structural backbone for aggregating signals. A Graph Neural Network (GNN) can propagate information along these edges, effectively summarizing the activity state of an entire pathway into a single embedding vector by convolving features across the graph's topology.

The application of graph convolutions to integrate multi-omic data structured as heterogeneous biological graphs. In the context of pathway-aware embeddings, GNN fusion operates directly on the pathway topology:

• Node features are initialized with gene expression, mutation status, or protein abundance
• Message passing propagates signals along known protein-protein interaction edges
• Readout layers aggregate node states into a fixed-length pathway-level embedding This approach captures non-linear, higher-order interactions that linear pathway scoring methods miss.

A fusion technique using attention mechanisms to dynamically weigh the importance of different omics layers for a specific prediction task. When generating a pathway-aware embedding, the model can learn to prioritize transcriptomic signals over proteomic signals for certain cascades while doing the opposite for others. This context-dependent weighting is critical because pathway activity may manifest differently across molecular layers depending on the biological condition or disease state being modeled.

The supervised learning task of forecasting organismal traits or disease states by integrating diverse molecular profiles. Pathway-aware embeddings serve as a powerful intermediate representation for this task. Instead of feeding thousands of individual gene features into a classifier, the model operates on a compact set of pathway activity scores. This dimensionality reduction combats the curse of dimensionality, improves generalization, and produces models that align with how biologists conceptualize disease mechanisms.

The computational inference of causal regulatory interactions between transcription factors and target genes. Pathway-aware embeddings provide a mechanistic prior for this task by constraining the search space of possible interactions to those documented in pathway databases. By comparing the learned embedding weights against known network topologies, researchers can identify novel regulatory edges that are consistent with established pathway architecture, bridging the gap between data-driven discovery and curated biological knowledge.